ASCO 2010: Prognostic and predictive markers in breast cancer

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
265 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Jul 28, 2010

Dr Christoph Thomssen - Martin-Luther University, Halle, Germany

Dr Thomssen discusses the difficulties faced when developing personalised medicine and the importance of prognostic and predictive markers in this process. Dr Thomssen speaks about the importance of the BRCA1 and BRCA2 mutations and how the PARP expression of ER+/ER- tumours can be used as a predictive factor for chemotherapy. Looking forward to ASCO 2011, Dr Thomssen outlines his hopes for future advances in breast cancer research.

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more